SynthesisSports medicine (Auckland, N.Z.)2026
Caffeine Use in Sport: A Systematic Review and Meta-analysis of Acute Side Effects and Implications for Athlete Health and Safety.
Synthesis in Sports medicine (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiven the widespread use of caffeine among athletes, this meta-analysis quantifies the incidence of acute side effects associated with caffeine supplementation. Despite its well-established performance benefits, evidence on caffeine's side effects remains fragmented, as these outcomes are often reported only as secondary findings.
objectiveTo address this gap, we systematically reviewed and meta-analyzed evidence from randomized controlled trials on acute caffeine-related side effects in athletes.
methodsFollowing PRISMA guidelines, we searched five databases (MEDLINE, Scopus, Web of Science, Embase, Google Scholar) up to July 2025. Eligible studies were randomized controlled trials in athletes aged ≥ 15 years examining acute caffeine ingestion versus placebo with reported side effects. Risk of bias was assessed using PEDro and Cochrane criteria. Data on frequency and magnitude of side effects were pooled using random-effects meta-analyses, with subgroup and dose-response analyses.
resultsA total of 48 studies (940 athletes; 63% male, 37% female) were included in the systematic review, of which 38 were eligible for meta-analysis. The mean caffeine dose was 4.9 ± 2.4 mg/kg (range 1.3-12 mg/kg), commonly ingested as capsules or beverages. Compared with placebo, athletes who ingested caffeine self-reported significantly higher odds of headache (Log OR = 0.74, p < 0.001), abdominal discomfort (Log OR = 1.12, p < 0.001), increased feelings of vigor/activeness (classified in this review as a side effect for methodological consistency, although it may also reflect an ergogenic benefit; Log OR = 1.14, p < 0.001), tachycardia (Log OR = 1.47, p < 0.001; > fourfold higher odds compared with placebo), insomnia (Log OR = 1.20, p < 0.001), increased urine output (Log OR = 1.04, p < 0.001), anxiety (Log OR = 1.29, p < 0.001), and nervousness (Log OR = 0.82, p < 0.001). Meta-regression of dose-response effects showed a significant association between caffeine dose and tachycardia (slope = 0.31, p < 0.001), headache (slope = 0.23, p < 0.001), abdominal discomfort (slope = 0.29, p < 0.001), vigor/activeness (slope = 0.18, p < 0.001), increased urine output (slope = 0.28, p < 0.001), and anxiety (slope = 0.37, p < 0.001).
conclusionsCaffeine intake in athletes increases the likelihood of side effects in a dose-dependent manner, with tachycardia, insomnia, abdominal discomfort, and anxiety being the most consistent. Evidence suggests that, compared with high doses (> 6 mg/kg), low to moderate doses (≤ 6 mg/kg) of caffeine may reduce the risk of side effects.
Indexed as
Identifiers
42033594What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.